Evidence map›Paper›PMID 36908895›Full record

ArticleAging brain2022

Asymmetric amyloid deposition in preclinical Alzheimer's disease: A PET study.

Pernille L Kjeldsen, Peter Parbo, Kim V Hansen, Joel F A Aanerud, Rola Ismail, Peter H Nissen, Rikke B Dalby, Malene F Damholdt, Per Borghammer, David J Brooks

Abstract read
In one paragraph

Article in Aging brain, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. The Bidirectional Relationship Between Epilepsy and Alzheimer's Disease.Current neurology and neuroscience reports · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Pernille L KjeldsenDept. of Clinical Medicine, Aarhus University, Denmark.
Peter ParboDept. of Clinical Medicine, Aarhus University, Denmark.
Kim V HansenDept. of Nuclear Medicine and PET, Aarhus University Hospital, Denmark.
Joel F A AanerudDept. of Nuclear Medicine and PET, Aarhus University Hospital, Denmark.
Rola IsmailDept. of Nuclear Medicine, Vejle, Lillebælt Hospital, Denmark.
Peter H NissenDept. of Clinical Medicine, Aarhus University, Denmark.
Rikke B DalbyDept. of Clinical Medicine, Aarhus University, Denmark.
Malene F DamholdtDept. of Clinical Medicine, Aarhus University, Denmark.
Per BorghammerDept. of Clinical Medicine, Aarhus University, Denmark.
David J BrooksDept. of Clinical Medicine, Aarhus University, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The typical spatial pattern of amyloid-β (Aβ) in diagnosed Alzheimer's disease (AD) is that of a symmetrical hemispheric distribution. However, Aβ may be asymmetrically distributed in early stages of AD. Aβ distribution on PET has previously been explored in MCI and AD, but it has yet to be directly investigated in preclinical AD (pAD). We examined how Aβ was distributed in individuals with pAD and MCI using Methods: In this PET study, 79 subjects were retrospectively enrolled, including 34 controls, 24 pAD, and 21 MCI. All subjects underwent Results: The Aβ asymmetry index (AI) differed between groups, with pAD having the highest Aβ AI as compared to both controls and MCI. There was no clear Aβ lateralisation in pAD, but there was a non-significant trend towards Aβ being more left-lateralised in MCI. There were no correlations between the cognitive scores and Aβ AI or Aβ lateralisation in pAD or MCI. Conclusion: The distribution of Aβ is most asymmetrical in pAD, as Aβ first starts accumulating, and it then becomes less asymmetrical in MCI, when Aβ has spread further, suggesting that more pronounced asymmetrical Aβ distribution may be a distinguishing factor in pAD. Longitudinal studies examining the distribution of Aβ across the AD continuum are needed.

Indexed as

Amyloid depositionAsymmetryPositron emission tomographyPreclinical Alzheimer’s disease

Identifiers

PMID36908895
PMCPMC9997142

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.